Zoetis (ZTS) reported $2.04 billion in revenue for the quarter ended December 2022, representing a year-over-year increase of 3.7%. EPS of $1.15 for the same period compares to $1.00 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $2.01 billion, representing a surprise of +1.72%. The company has not delivered EPS surprise, with the consensus EPS estimate being $1.15.
While investors closely watch year-over-year changes in headline numbers — revenue and earnings — and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company’s underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock’s price performance more accurately.
Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenues-U.S.-Livestock: $259 million versus $262.15 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.5% change.
- Geographic Revenues-U.S.-Companion Animal: $853 million versus the three-analyst average estimate of $813.12 million. The reported number represents a year-over-year change of +11.8%.
- Geographic Revenues-International-Companion Animal: $450 million versus the three-analyst average estimate of $446.62 million. The reported number represents a year-over-year change of +7.4%.
- Geographic Revenues-International-Livestock: $451 million compared to the $460.72 million average estimate based on three analysts. The reported number represents a change of -6.6% year over year.
- Geographic Revenues- International Revenue: $901.30 million compared to the $907.38 million average estimate based on three analysts. The reported number represents a change of -0.1% year over year.
- Revenues-Livestock- Sheep and other: $19 million versus the four-analyst average estimate of $20.29 million. The reported number represents a year-over-year change of -74.3%.
- Revenues-Companion Animal: $1.30 billion compared to the $1.26 billion average estimate based on three analysts. The reported number represents a change of +10.2% year over year.
- Revenue-Contract Manufacturing & Human Health: $27 million versus the three-analyst average estimate of $23.83 million. The reported number represents a year-over-year change of +8%.
- Revenues-Livestock: $710 million versus $722.87 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.6% change.
View all Key Company Metrics for Zoetis here>>>
Shares of Zoetis have returned +1.4% over the past month versus the Zacks S&P 500 composite’s +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Is THIS the Ultimate New Clean Energy Source? (4 Ways to Profit)
The world is increasingly focused on eliminating fossil fuels and ramping up use of renewable, clean energy sources. Hydrogen fuel cells, powered by the most abundant substance in the universe, could provide an unlimited amount of ultra-clean energy for multiple industries.
Our urgent special report reveals 4 hydrogen stocks primed for big gains – plus our other top clean energy stocks.
Zoetis Inc. (ZTS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.